Intuitive Surgical’s Stock Surges on Robotic Procedure Demand
Intuitive Surgical shares rallied sharply after the company reported third-quarter earnings that significantly exceeded analyst expectations. The Maker of robotic surgical systems posted adjusted EPS of $2.40, beating estimates by $0.42, while revenue jumped 23% to $2.51 billion.
The company raised its full-year guidance for da Vinci procedure growth to 17-17.5%, up from previous projections of 15.5-17%. Gross margin forecasts were also revised upward to 67-67.5%. This optimistic outlook sent shares soaring 14%, erasing year-to-date losses.
William Blair analysts noted the company maintains dominant market positioning. The results underscore accelerating adoption of minimally invasive robotic surgery technology globally, with both procedure volumes and system placements showing strong growth.
